Page 3 - Michael Levitan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pharming Group N V : Pharming Group reports first quarter 2024 financial results and provides business update

Pharming Group N V : Pharming Group reports first quarter 2024 financial results and provides business update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomNoord hollandCity ofAsia pacificExperte carsten storkZwei rohstoff chancenFoster mitchell alex shawMichael levitanExchange commissionKamada ltdPharming groupnvEuropean medicines agencyCompany theVp investor relations corporate communicationsAccess program

Pharming N : Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025 - Form 6-K

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 .

United statesSouth africaCity ofUnited kingdomNoord hollandAmerican samoaMichael levitanVan lanschot kempenLifespring life sciences communicationCompany theCommission file numberExchange commissionPharming groupCompany euronext amsterdamVp investor relations corporate communicationsFrankfurt stock exchange

Pharming Group To Report First Quarter 2024 Financial Results On May 8

Pharming Group To Report First Quarter 2024 Financial Results On May 8
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Noord hollandCity ofUnited kingdomUnited statesMichael levitanVp investor relations corporate communicationsPharming groupnv euronext amsterdamPharming groupLifespring life sciences communicationEuronext amsterdamNorth americaMiddle eastSpring life sciences communication

Pharming N : to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards - Form 6-K

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 .

Noord hollandUnited statesUnited kingdomCity ofChristina renfroeStephen toorMichael levitanPeter saltonstallDrug administrationIndustry innovator at nationalExchange commissionOrganization for rare disordersCommission file numberSecurities exchangePharming groupPharming groupnv

Pharming Group to report first quarter 2024 financial

Leiden, the Netherlands, April 24, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary.

Noord hollandUnited kingdomCity ofUnited statesMichael levitanPharming groupnv euronext amsterdamLifespring life sciences communicationVp investor relations corporate communicationsPharming groupEuronext amsterdamNorth americaMiddle eastSpring life sciences communicationAmsterdam stock exchange pharmPharming groupnv